BioRestorative Therapies, Inc.

A clinical-stage company developing stem cell therapies for pain, metabolic disorders, and aesthetics.

BRTX | US

Overview

Corporate Details

ISIN(s):: US0906556065
LEI:
Country:: United States of America
Address:: 40 MARCUS DRIVE, 11747 MELVILLE
Website:: https://www.biorestorative.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

BioRestorative Therapies, Inc. is a clinical-stage regenerative medicine company focused on developing therapeutic products using advanced cell and tissue protocols, primarily involving adult stem cells. The company's lead clinical program centers on BRTX-100, an investigational single-dose therapy derived from bone marrow mesenchymal stem cells, which is in a Phase 2 trial for treating chronic lumbar disc disease. In addition to addressing chronic pain, BioRestorative is developing a pipeline of brown adipose-derived stem cell therapies for metabolic disorders. The company also has a commercial-facing BioCosmeceutical platform that leverages its secretome and exosome-based biologics for applications in aesthetic medicine.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BioRestorative Therapies, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioRestorative Therapies, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for BioRestorative Therapies, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
FATE THERAPEUTICS INC Develops off-the-shelf iPSC cell therapies for cancer and autoimmune diseases.	United States of America	FATE
FENNEC PHARMACEUTICALS INC. Prevents chemotherapy-induced hearing loss in children with its sole product, PEDMARK®.	United States of America	FENC
FibroBiologics, Inc. Clinical-stage biotech developing fibroblast cell therapies for chronic diseases.	United States of America	FBLG
FIBROGEN INC Biopharma developing first-in-class therapies for cancer, anemia, and serious conditions.	United States of America	FGEN
Fine Foods & Pharmaceuticals Ntm Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.	Italy	FF
Flora Growth Corp. A diversified firm in pharma distribution, plant-based wellness, and digital assets.	United States of America	FLGC
Foghorn Therapeutics Inc. Pioneering medicines targeting the chromatin regulatory system to treat genetically defined cancers.	United States of America	FHTX
Formycon AG Develops cost-effective biosimilars for ophthalmology, immunology, and other chronic diseases.	Germany	FYB
Fortress Biotech, Inc. Acquires, develops, and commercializes drugs for oncology, gene therapy, and rare diseases.	United States of America	FBIO
FRACTYL HEALTH, INC. Developing gut-targeted endoscopic and gene therapies for obesity and type 2 diabetes.	United States of America	GUTS